Close Menu

capillary electrophoresis

BillionToOne's assay detects SARS-CoV-2 in samples from nasal, nasopharyngeal, and oropharyngeal swabs and has a testing capacity of 1 million tests per day.

The two tests, both of which use RT-PCR technology to detect multiple viral targets, may be performed only by their respective developers.

The firm's AmplideX Fragile X Dx and Carrier Screen Kit is intended to help diagnose fragile X syndrome and assess parental risk of having a child with the syndrome.

The assay was shown to have a simpler workflow and was able to detect mosaicism, with only a slight decrease in sensitivity compared to a lab-developed test.

Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio.

Advanced Analytical markets CE instruments, reagents, and software for nucleic acid analysis while Lasergen is a next-generation sequencing technology developer.

The Spectrum Compact instrument.

The firm's target market for the instruments will include existing customers in the forensics and food testing spaces.

Timothy Kupferschmid

OCME's Department of Forensic Biology recently started testing next-generation sequencing for forensic applications.

NEW YORK (GenomeWeb) — DxTerity Diagnostics has begun commercializing blood sample collection products and a multiplex PCR reagent kit.

NEW YORK (GenomeWeb) – PerkinElmer has signed an agreement to serve as the exclusive global distributor for Sebia's Capillarys 2 Neonat Fast system for labs conducting newborn screening.

Pages

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.